Literature DB >> 20057426

Kidney complications: factors that protect the diabetic vasculature.

Christian Rask-Madsen1, George L King.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20057426     DOI： 10.1038/nm0110-40

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.

Authors:  Vera Eremina; Shiying Cui; Hanspeter Gerber; Napoleone Ferrara; Jody Haigh; Andras Nagy; Masatsugu Ema; Janet Rossant; Serge Jothy; Jeffrey H Miner; Susan E Quaggin
Journal:  J Am Soc Nephrol       Date:  2006-01-25       Impact factor: 10.121

2.  Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study.

Authors:  Hillary A Keenan; Tina Costacou; Jennifer K Sun; Alessandro Doria; Jerry Cavellerano; Joseph Coney; Trevor J Orchard; Lloyd Paul Aiello; George L King
Journal:  Diabetes Care       Date:  2007-05-16       Impact factor: 19.112

3.  Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.

Authors:  Vera Eremina; Manish Sood; Jody Haigh; András Nagy; Ginette Lajoie; Napoleone Ferrara; Hans-Peter Gerber; Yamato Kikkawa; Jeffrey H Miner; Susan E Quaggin
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

4.  Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.

Authors:  Berend Isermann; Ilya A Vinnikov; Thati Madhusudhan; Stefanie Herzog; Muhammed Kashif; Janusch Blautzik; Marcus A F Corat; Martin Zeier; Erwin Blessing; Jun Oh; Bruce Gerlitz; David T Berg; Brian W Grinnell; Triantafyllos Chavakis; Charles T Esmon; Hartmut Weiler; Angelika Bierhaus; Peter P Nawroth
Journal:  Nat Med       Date:  2007-11-04       Impact factor: 53.440

Review 5.  Vascular endothelial growth factor and diabetic nephropathy.

Authors:  Sheldon Chen; Fuad N Ziyadeh
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

6.  Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy.

Authors:  Pedro Geraldes; Junko Hiraoka-Yamamoto; Motonobu Matsumoto; Allen Clermont; Michael Leitges; Andre Marette; Lloyd P Aiello; Timothy S Kern; George L King
Journal:  Nat Med       Date:  2009-11-01       Impact factor: 53.440

7.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1984-04

8.  VEGF inhibition and renal thrombotic microangiopathy.

Authors:  Vera Eremina; J Ashley Jefferson; Jolanta Kowalewska; Howard Hochster; Mark Haas; Joseph Weisstuch; Catherine Richardson; Jeffrey B Kopp; M Golam Kabir; Peter H Backx; Hans-Peter Gerber; Napoleone Ferrara; Laura Barisoni; Charles E Alpers; Susan E Quaggin
Journal:  N Engl J Med       Date:  2008-03-13       Impact factor: 91.245

Review 9.  Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy.

Authors:  R Simó; C Hernández
Journal:  Diabetologia       Date:  2008-04-11       Impact factor: 10.122

10.  Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathy.

Authors:  Michael I Dorrell; Edith Aguilar; Ruth Jacobson; Sunia A Trauger; Jeffrey Friedlander; Gary Siuzdak; Martin Friedlander
Journal:  Glia       Date:  2010-01-01       Impact factor: 7.452
  10 in total
  14 in total

1.  Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice.

Authors:  Yanling Liu; Lan Franco Leo; Corban McGregor; Anzor Grivitishvili; Colin J Barnstable; Joyce Tombran-Tink
Journal:  Mol Med       Date:  2012-12-20       Impact factor: 6.354

2.  Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy.

Authors:  Sebastian Oltean; Yan Qiu; Joanne K Ferguson; Megan Stevens; Chris Neal; Amy Russell; Amit Kaura; Kenton P Arkill; Kirstie Harris; Clare Symonds; Katja Lacey; Lihini Wijeyaratne; Melissa Gammons; Emma Wylie; Richard P Hulse; Chloe Alsop; George Cope; Gopinath Damodaran; Kai B Betteridge; Raina Ramnath; Simon C Satchell; Rebecca R Foster; Kurt Ballmer-Hofer; Lucy F Donaldson; Jonathan Barratt; Hans J Baelde; Steven J Harper; David O Bates; Andrew H J Salmon
Journal:  J Am Soc Nephrol       Date:  2014-12-26       Impact factor: 10.121

Review 3.  Diabetic retinopathy: current understanding, mechanisms, and treatment strategies.

Authors:  Elia J Duh; Jennifer K Sun; Alan W Stitt
Journal:  JCI Insight       Date:  2017-07-20

Review 4.  Implications of treatment that target protective mechanisms against diabetic nephropathy.

Authors:  Akira Mima; Weier Qi; George L King
Journal:  Semin Nephrol       Date:  2012-09       Impact factor: 5.299

Review 5.  The role of the Janus kinase family/signal transducer and activator of transcription signaling pathway in fibrotic renal disease.

Authors:  Futoshi Matsui; Kirstan K Meldrum
Journal:  J Surg Res       Date:  2012-07-17       Impact factor: 2.192

6.  NRF2 plays a protective role in diabetic retinopathy in mice.

Authors:  Zhenhua Xu; Yanhong Wei; Junsong Gong; Hongkwan Cho; James K Park; Ee-Rah Sung; Hu Huang; Lijuan Wu; Charles Eberhart; James T Handa; Yunpeng Du; Timothy S Kern; Rajesh Thimmulappa; Alistair J Barber; Shyam Biswal; Elia J Duh
Journal:  Diabetologia       Date:  2013-11-03       Impact factor: 10.122

Review 7.  Molecular mechanisms of diabetic vascular complications.

Authors:  Munehiro Kitada; Zhaoyun Zhang; Akira Mima; George L King
Journal:  J Diabetes Investig       Date:  2010-06-01       Impact factor: 4.232

Review 8.  Mechanism of hypertension in diabetic nephropathy.

Authors:  Chaudhary Muhammad Junaid Nazar
Journal:  J Nephropharmacol       Date:  2014-07-01

9.  Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay.

Authors:  Loredana Fiorentino; Michele Cavalera; Stefano Menini; Valentina Marchetti; Maria Mavilio; Marta Fabrizi; Francesca Conserva; Viviana Casagrande; Rossella Menghini; Paola Pontrelli; Ivan Arisi; Mara D'Onofrio; Davide Lauro; Rama Khokha; Domenico Accili; Giuseppe Pugliese; Loreto Gesualdo; Renato Lauro; Massimo Federici
Journal:  EMBO Mol Med       Date:  2013-02-12       Impact factor: 12.137

10.  TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes.

Authors:  Feng Jiang; Qingzhong Chen; Liming Huang; Ying Wang; Zhuhong Zhang; Xiangda Meng; Yuanyuan Liu; Chunjie Mao; Fang Zheng; Jingkai Zhang; Hua Yan
Journal:  Int J Mol Sci       Date:  2016-04-25       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.